TCS Connected Clinical Trials Platform Wins the 2020 Citeline Award

Mumbai: Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting, and business solutions organization, announced that its TCS Connected Clinical Trials (CCT) platform has won the 2020 Citeline Award in the category ‘Best Patient-facing Technology Initiative’. CCT won the award for providing a positive experience to patients participating in clinical trials as well as unlocking superior efficiencies in the overall clinical trials process for sponsors, sites, and niche providers.

The awards, presented by Informa Pharma Intelligence, honor the achievements of those working to advance the quality of human healthcare worldwide by contributing toward bringing new and needed medicines to market. The nominations went through a rigorous review by an independent panel of volunteers from the top echelons of all sectors of the clinical R&D industry, who used their deep knowledge to score entries against the judging criteria.

Part of the TCS ADD platform, CCT is an innovative, cloud-based platform that enables real-time data integration, data-driven analytics and personalized patient support through smart technologies, wearables and mobile apps. It provides end-to-end visibility at patient and site level and lays the foundation for decentralized trials. The platform comprises patient and site engagement, supply management and devices, and connections capabilities.

“With COVID-19 significantly impacting clinical trials, life sciences industries, empowered with technology, are transitioning to a state of decentralized or virtual trials that eliminate the inefficiencies linked with the traditional site-centric approach and embed clinical trials into the daily lives of patients,” said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. “This award validates our focus on providing life sciences organizations with novel technologies and broad cross-stakeholder partnerships to enable decentralized trials, thereby significantly enriching patient engagement, and enhancing test protocol adherence and outcomes.”

“This year’s digital event showcased the remarkable innovation, commitment and achievement present across the industry. We are incredibly proud to provide the opportunity to recognize those working in pharma and related industries to drive medical breakthroughs and enhance human health,” said Karen Currie, Executive Director, Citeline. “While the format of the event is virtual this year, the same high standards of excellence in clinical research and drug development are evident in the achievements of this year’s winners including TCS Connected Clinical Trials.”